Opinion

Video

Main Goals in the Management of NF1-PN

Panelists discuss the current management goals for NF1-associated plexiform neurofibromas, focusing on tumor control, symptom management, and prevention of malignant transformation, while highlighting the evolving future goals of targeted therapies, personalized treatment plans, and enhanced early detection to improve outcomes.

Summary for Physicians

Current Management Goals for NF1-PN

The primary goals in managing neurofibromatosis type 1–associated plexiform neurofibromas (NF1-PN) are to control tumor growth, manage symptoms (pain, disfigurement, neurological impairment), and prevent malignant transformation. Treatment strategies focus on monitoring tumor progression, surgical resection when feasible, and symptomatic management (eg, pain relief, functional support).

Future Evolving Goals

As research advances, future management may focus on targeted therapies aimed at the molecular drivers of NF1-PN, such as RAS/MAPK pathway inhibitors or gene therapies. Additionally, there is potential for earlier intervention with personalized treatment plans based on genetic profiling. Enhanced early detection and preventive strategies for malignancy may also become key components of care.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
4 experts in this video
1 expert is featured in this series.
5 experts are featured in this series
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo